Profile avatar
hswapnil.medsky.social
Nephrologist = kidney doctor MD, MPH University of Ottawa/Ottawa Hospital 🇨🇦 Unceded territory of the Anishinaaben Algonquin nation He/Him/His No PhRMA conflict #NephJC co-creator, @FreelyFiltered.bsky.social pod panelist #MedSky #NephSky #SkyNeph
2,410 posts 5,218 followers 2,997 following
Regular Contributor
Active Commenter

I think it’s time that regulator require companies to make open up software rather than retire it which makes technology useless junk

The Australians with a clear recommendation to use balanced solutions (they don’t specify Plasmalyte) in kidney transplant www.kireports.org/article/S246... in @kireports.bsky.social #NephSky #Transplant #EMIMCC

Part 2 published! Last week was glucagon antagonists, this week, glucagon agonists. They're coming in 2026 and they're about to make Ozempic obsolete. Read on and find out why glucagon, once shunned by medicine is about to have its moment in the spotlight

Almost (more than) 2 decades of running the hospital like his personal empire ottawacitizen.com/news/supervi... From @egpayne.bsky.social #OnPoli

Pretty egregious error from this book: The authors say Swedish deaths fell by 2.3% during the pandemic, proving that the country's lax lockdown strategy worked. But they misread their source: Mortality is only down if you remove the COVID deaths. research.abo.fi/ws/portalfil...

CONFIDENCE: Finerenone with Empagliflozin in CKD and T2D from @nejm.org #ERA25 🇦🇹 #Nephpearls #NephSky 📌 Among persons with both CKD and T2D, initial therapy with finerenone plus empagliflozin led to a greater reduction in the UACR than either treatment alone 👉 pubmed.ncbi.nlm.nih.gov/40470996/

We have an official ruling

Related commentary from @jbrianbyrd.bsky.social and colleagues academic.oup.com/ajh/article/... Is Hypertension too important to be left for physicians?

Another great talk about Green Nephrology - finally somebody mentions Hemingway: “Do not send somebody to find out for whom the bell tolls: it tolls for thee” (originally by John Donne) #ERA25

Kentucky OPO horror stories www.nytimes.com/2025/06/06/u... DCD instances that clearly should not have proceeded #NephSky #OrganDonation h/t @picardonhealth.bsky.social

Survival advantages of deceased-donor kidney transplantation don't apply to all patients and donor organs, findings presented at #ERA25 suggested. #nephrology #nephsky #kidneytransplant #transplantation www.docwirenews.com/post/limited...

Great #ACHIEVE ment by @lastwalsh.bsky.social and colleagues presented at the #ERA25. An important study that will hopefully be published accordingly.

Appraise for the interim analysis of the #VISIONARY trial in IgAN at #ERA25

iSGLT2 effects on Acute Kidney Outcomes #ERA25 ✅ Clear protective effects for AKI ❌ No extra risk of AKI events during the acute eGFR dip

ACHIEVE trial - Spironolactone in Hemodialysis stopped early... due to futility 😢 I had some hopes for this one. #ERA25

Very good (often neglected) point about the cost of KRT on patients and family. #era25

ISGD President @tobias-b-huber.bsky.social advocating for redefining diseases according to endotype rather than histotype on the plenary stage at #ERA25

Awesome late breaking clinical trials session II session #ERA25 @brendonneuen.bsky.social

Forget about it - the dip (after starting SGLT-2i) nicely played tune at the #ERA25.

You know this @brittlestar.com gif was always my go-to Trump45 gif. But I haven't felt like posting it for Trump47, because it's felt a bit like the US News is about to pull aside the curtain next to me and say "Hello, Canada..." and I'd drop my chips. But today... Oh yes. Today I can post this gif

Some good news for a change–Queen's has set aside funds to assist any students who have lost their visa status in the US and are looking to continue their graduate studies. Please share widely. www.queensu.ca/grad-postdoc...

I'm just glad one of these men has the nuclear codes and the other has all our personal data.

Quick. Somebody tell Trump that the best way to own Elon is to restore all research grants and double NSF funding.